QLH

5-[(3~{R},5~{S})-3-azanyl-5-(trifluoromethyl)piperidin-1-yl]quinoline-8-carbonitrile

Created:	2020-06-29
Last modified:	2020-12-30

Find Related PDB Entry
1 entries where QLH is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	38
Chiral Atom Count	2
Bond Count	40
Aromatic Bond Count	11

2D diagram of QLH

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-[(3~{R},5~{S})-3-azanyl-5-(trifluoromethyl)piperidin-1-yl]quinoline-8-carbonitrile
Systematic Name (OpenEye OEToolkits)	5-[(3~{R},5~{S})-3-azanyl-5-(trifluoromethyl)piperidin-1-yl]quinoline-8-carbonitrile
Formula	C₁₆ H₁₅ F₃ N₄
Molecular Weight	320.312
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	N[CH]1C[CH](CN(C1)c2ccc(C#N)c3ncccc23)C(F)(F)F
SMILES	OpenEye OEToolkits	2.0.7	c1cc2c(ccc(c2nc1)C#N)N3CC(CC(C3)N)C(F)(F)F
Canonical SMILES	CACTVS	3.385	N[C@@H]1C[C@@H](CN(C1)c2ccc(C#N)c3ncccc23)C(F)(F)F
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc2c(ccc(c2nc1)C#N)N3C[C@H](C[C@H](C3)N)C(F)(F)F
InChI	InChI	1.03	InChI=1S/C16H15F3N4/c17-16(18,19)11-6-12(21)9-23(8-11)14-4-3-10(7-20)15-13(14)2-1-5-22-15/h1-5,11-12H,6,8-9,21H2/t11-,12+/m0/s1
InChIKey	InChI	1.03	BJXYHBKEQFQVES-NWDGAFQWSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB16501
Name	Enpatoran
Groups	investigational
Description	Enpatoran (M5049) was under investigation in clinical trials for various conditions. It was investigated for systemic lupus erythematosus and cutaneous lupus erythematosus in completed trials (NCT04647708 and NCT05162586) and in a recruiting trial (NCT05540327). Additionally, M5049 was studied for COVID-19 pneumonia in a completed trial with results (NCT04448756) and is currently being recruited for a trial involving participants with dermatomyositis and polymyositis (NCT05650567).
Synonyms	5-((3R,5S)-3-AMINO-5-TRIFLUOROMETHYLPIPERIDIN-1-YL)QUINOLINE-8-CARBONITRILE Enpatoran
Categories	Experimental Unapproved Treatments for COVID-19
CAS number	2101938-42-3

Related Resource References

Resource Name	Reference
PubChem	129240620

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.